Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety
在一项评估阴道内使用3% StarPharma LTD 7013凝胶(VivaGel)的I期临床试验中,测量黏膜生物标志物以扩大安全性。
期刊:Jaids-Journal of Acquired Immune Deficiency Syndromes
影响因子:2.2
doi:10.1097/QAI.0b013e31823f2aeb
Moscicki, Anna-Barbara; Kaul, Rupert; Ma, Yifei; Scott, Mark E; Daud, Ibrahim I; Bukusi, Elizabeth A; Shiboski, Stephen; Rebbapragada, Anuradha; Huibner, Sanja; Cohen, Craig R